Expression of Cytochrome P450 Enzymes in Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Possible Role in Carcinogenesis and Treatment Response

Cytochrome b5 impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b5/P450 reductase null (HBRN) mice

(2018) Lindsay Reed et al.   ARCHIVES OF TOXICOLOGY

MDR1 not CYP3A4 gene expression is the predominant mechanism of innate drug resistance in pediatric soft tissue sarcoma patients

(2018) Dora Molina-Ortiz et al.   Cancer Biomarkers

Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment

(2018) Gabriele D'Uva et al.   CANCER TREATMENT REVIEWS

A review of soft-tissue sarcomas: translation of biological advances into treatment measures

(2018) Ngoc T Hoang et al.   Cancer Management and Research

The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma

(2018) Tingdong Yu et al.   Cancer Management and Research

Expression of CYP and GST in human normal and colon tumor tissues

(2018) H Bulus et al.   BIOTECHNIC & HISTOCHEMISTRY

Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts

(2017) Winette T A van der Graaf et al.   LANCET ONCOLOGY

The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma

(2017) Mao Qixing et al.   TUMOR BIOLOGY

CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response

(2017) Alini Trujillo-Paolillo et al.   Oncotarget

CYP gene expressions in obesity-associated metabolic syndrome

(2016) Suzan Tabur et al.   Obesity Research & Clinical Practice

Non-rhabdomyosarcoma

(2016) Roshni Dasgupta et al.   Seminars in Pediatric Surgery

CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation

(2015) Hamid Zia et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression

(2015) Jiahua Cui et al.   JOURNAL OF MEDICINAL CHEMISTRY

Sarcomas

(2015) Josephine H. HaDuong et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Polycyclic Aromatic Hydrocarbons: From Metabolism to Lung Cancer

(2015) Bhagavatula Moorthy et al.   TOXICOLOGICAL SCIENCES

CYP3A4 Expression in Breast Cancer and its Association with Risk Factors in Mexican Women

(2014) Esau Floriano-Sanchez et al.   Asian Pacific Journal of Cancer Prevention

The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts

(2014) Kirsten Linhart et al.   Redox Biology

Expression Profile of CYP1A1 and CYP1B1 Enzymes in Colon and Bladder Tumors

(2013) Vasilis P. Androutsopoulos et al.   PLoS One

CYP3A5 Polymorphism in Mexican Renal Transplant Recipients and its Association with Tacrolimus Dosing

(2012) Pilar García-Roca et al.   ARCHIVES OF MEDICAL RESEARCH

Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53

(2012) Ido Goldstein et al.   CARCINOGENESIS

Revised RECIST Guideline Version 1.1: What Oncologists Want to Know and What Radiologists Need to Know

(2010) Mizuki Nishino et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

CYP2E1 and risk of chemically mediated cancers

(2010) Dimitrios T Trafalis et al.   Expert Opinion on Drug Metabolism & Toxicology

Profiling the expression of cytochrome P450 in breast cancer

(2010) Graeme I Murray et al.   HISTOPATHOLOGY